Physiological markers for immunotherapeutics: a review DOI

Durlav Chowdhury,

Ashmita Das,

Mrityunjay Mishra

и другие.

Journal of Chemotherapy, Год журнала: 2024, Номер unknown, С. 1 - 24

Опубликована: Дек. 22, 2024

Immunotherapy has been advanced through multiple approaches, including immunogenic cytokines, monoclonal antibodies, therapeutic vaccinations, adoptive cell transfer, stem transplantation, and oncolytic viruses. This review analyses various strategies in genomics, transcriptomics, single-cell techniques, computational analysis, big data, imaging technologies for the identification of tumour microbiota microenvironments. is becoming acknowledged as a feasible cancer treatment method, facilitating innovative medicines personalized medicine techniques.

Язык: Английский

Metrology for MRI: the field you’ve never heard of DOI Creative Commons
Matt G. Hall,

Matt Cashmore,

Hyo-Min Cho

и другие.

Magnetic Resonance Materials in Physics Biology and Medicine, Год журнала: 2025, Номер unknown

Опубликована: Март 19, 2025

Quantitative MRI has been an active area of research for decades and produced a huge range approaches with enormous potential patient benefit. In many cases, however, there are challenges reproducibility which have hampered clinical translation. is form measurement like any other it requires supporting metrological framework to be fully consistent compatible the international system units. This means not just expressing results in terms seconds, meters, etc., but demonstrating consistency their internationally recognized definitions. Such yet complete, considerable amount work done towards building one. article describes current state art metrology, including detailed description principles how they relevant quantitative MRI. It also undertakes gap analysis where we versus need support focusses particularly on role activities national institutes across globe, illustrating genuinely collaborative nature field.

Язык: Английский

Процитировано

1

[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy DOI
Jelena Levi, Millie Das, Minal Vasanawala

и другие.

Journal of Nuclear Medicine, Год журнала: 2024, Номер unknown, С. jnumed.124.268253 - jnumed.124.268253

Опубликована: Окт. 24, 2024

Despite the systemic impact of both cancer and associated immune response, immuno-PET is predominantly centered on assessment milieu within tumor microenvironment. The aim this study was to assess value [18F]F-AraG PET imaging as a noninvasive method for evaluation system-wide status patients with non–small cell lung before starting immunotherapy. Methods: Eleven advanced were imaged Diagnostic [18F]FDG PET/CT scans analyzed differences in extent disease among patients. SUVmax, SUVmean, total SUV (SUVtotal) from all lesions, active lymph nodes, spleen, vertebral bone marrow, liver, thyroid, heart, bowel extracted baseline scans, discriminant Kaplan–Meier analyses performed test their ability predict patient response overall survival. Results: variable cohort, but none biomarkers burden (SUVmax, metabolic volume, lesion glycolysis) predictive distribution observed between confirming that they capture distinct aspects Of 3 parameters studied, SUVtotal provided dynamic range suitable stratifying tumors or according activity. measured lumbar sacral vertebrae differentiated who progressed therapy those did not 90.9% 81.8% accuracy, respectively. analysis revealed high marrow had significantly lower probability survival than low signal (P = 0.0003). Conclusion: This highlights significance assessing immunity indicates potential biomarker stratification treatment guidance.

Язык: Английский

Процитировано

1

Physiological markers for immunotherapeutics: a review DOI

Durlav Chowdhury,

Ashmita Das,

Mrityunjay Mishra

и другие.

Journal of Chemotherapy, Год журнала: 2024, Номер unknown, С. 1 - 24

Опубликована: Дек. 22, 2024

Immunotherapy has been advanced through multiple approaches, including immunogenic cytokines, monoclonal antibodies, therapeutic vaccinations, adoptive cell transfer, stem transplantation, and oncolytic viruses. This review analyses various strategies in genomics, transcriptomics, single-cell techniques, computational analysis, big data, imaging technologies for the identification of tumour microbiota microenvironments. is becoming acknowledged as a feasible cancer treatment method, facilitating innovative medicines personalized medicine techniques.

Язык: Английский

Процитировано

0